ADIPOQ and metabolic syndrome: The adiponectin concentration in T2DM participants without MetS at the first measurement was 41.4 ± 1.31 ng/mL, significantly higher than that of adiponectin measured secondly (40.07 (38.5–35.2) ng/mL; p = 0.023).